Powered by: Motilal Oswal
2026-04-29 12:54:18 pm | Source: Elara Capital
Buy Rallis India Ltd For Target Rs.355 by Elara Capital
Buy Rallis India Ltd For Target Rs.355  by Elara Capital

Turnaround efforts bearing fruit

Rallis India (RALI IN) reported top-line growth of 6%, in line with our estimates, fueled by 5% volume gains and 1% price hike. Growth spanned all segments except B2B. Gross margin expanded, driven by the soil & plant health business, custom synthesis segment, and the seeds business. Crop protection business margin was steady amid liquidation of low-margin products.

Since Gyanendra Shukla’s appointment as MD & CEO, targeted efforts are on to revive its glory days – with results emerging and more to come. A strong H1FY27 agrochemicals season should accelerate superior earnings growth. We retain Buy with a higher TP of INR 355.

Normalcy creeping in raw materials availability: Post Iran-US war, there was a phase when the industry was facing force majeure from suppliers. That is now over, and normalcy is creeping in gradually. Materials are available; they may not be abundant, but supplies  continue. Post war, the crop protection market has shifted from a buyer’s market to seller’s. Prices have increased by ~20-25%, as per management. RALI is adequately stocked for the Kharif season and does not want to buildup inventory within the company.

Seeds business is set to grow in the double digits: RALI’s strategy to drive scale and efficiency in the seeds business is focused on five crops: cotton, maize (corn), millets, mustard, and rice. We expect the seeds business to continue to grow in the double digits, driven by volume growth and realization leg-up. Cotton would continue to drive seeds business growth.

B2C business grows 15%, driven by legacy brands: Around 5% growth in the crop care business in Q4 was driven by 15% growth in the B2C business and 27% growth in the soil & plant health business. Legacy brands drove growth in the formulations space. RALI has launched two new insecticides brands: 1) ALSTOR – which is a combination of chlorantraniliprole and fipronil to control stem borer in paddy, and 2) FIPLAM – a patented combination of fipronil and lambda to control thrips, jassids and borers in cotton and horticulture crops, such as tomato, chilli, and onion. The B2B segment revenue declined 7%, due to lower volume.

Retain Buy with a higher TP of INR 355: While the Kharif season is likely to coincide with the El Nino phenomenon, we expect crop protection consumption to grow in India. Skymet’s monthly rainfall distribution forecast of 101%/95%/92%/89% of LPA for June/July/August/ September shows volatility in-between the Monsoon months is likely to be lower. Similarly, State-wise rainfall distribution forecast data does not indicate acute shortage in any of the agriculturally important states. Hence, we expect RALI to deliver healthy top-line growth and profitability. We increase our profitability assumptions for the seeds business, which has led to EBITDA growth of 7% for FY27E and 2% for FY28E. We introduce FY29 estimates. We retain Buy with a higher TP of INR 355 from INR 313 based on 20x (unchanged) FY28E EPS of INR 17.8.

 

Please refer disclaimer at Report
SEBI Registration number is INH000000933

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here